- Advanced Transitional Cell Carcinoma treatment with Docetaxel and Gemcitabine Phase I
- Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
- New biomarker test could predict outcome for bladder cancer patients
- New Study Seeks Better Outcomes for Kidney Cancer
- Bladder Cancer Basics
- Basque Research
- EntreMed Starts Phase II Clinical Trial of Panzem with Sutent for Kidney Cancer Patie
- Cryoablation -- A new treatment option for some kidney tumor patients
- Scientists find one reason why bladder cancer hits more men
- HHMI News: Kidney Cancer Shuts Down Protein Destruction Complex
- Doctors conclude temsirolimus is effective new treatment for advanced renal cell carc
- FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of A
- Glowing dye improves cancer removal in kidney
- St. Jude study shows temporary improvement of tumor blood flow can improve chemothera
- First Multiple Drug Trial to Attack Blood Vessel Formation in Kidney Cancer
- Study shows blood markers can help choose best dose for antiangiogenic drugs
- AUA releases new guidelines on non-muscle invasive bladder cancer
- How less can be more when treating some juvenile kidney cancers
- Kidney Cancer Surgery Often Determined By Surgeons? Abilities
- Hospital Clinic conducts the first kidney extraction through the vagina in Europe
- Patients unaware of link between smoking and bladder cancer
- Bladder cancer detected via amplified gene in cells found in urine
- Why bladder cancer is deadlier for some
- Unraveling kidney cancer
- Promising results shown for kidney cancer drug
- anyone using sorafenib for RCC
- Chemotherapy plus radiation prevents bladder cancer recurrences
- Avastin in Renal Cancer
- Chemosensitivity Test for Superficial Bladder Cancer Based on 3D Culture
- FDA Approves Inlyta For Advanced Kidney Cancer
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- Robotic surgery extends benefits to bladder cancer patients
- Foretinib demonstrated activity in patients with papillary renal cell carcinoma